---
layout: talk_reveal4
title: Evolutionary dynamics of SARS-CoV-2
venue: ASV Annual Meeting
event: Symposium on Understanding How Viruses Spread and Evolve
author: Trevor Bedford
widescreen: true
draft: true
---

<!-- 30 min total, no Q&A -->

<!--
Outline

1. Variant viruses introduction
 - variant viruses and population turnover
 - what does this mean for vaccination and burden of disease?

2. Forecasting seasonal influenza evolution (maybe)

3. SARS-CoV-2 genome evolution
 - mutation accumulation and clade growth
 - rate of evolution by dN/dS
 - comparison of rate to other antigenically evolving viruses

4. Variant frequency dynamics
 - SARS-CoV-2 and amazing consistency of frequency dynamics
 - multinomial logistic regression models
 - growth advantages of recent variants
 - Obermeyer hierarchical MLR work
 - (ideally) comparison of growth advantages to influenza

5. Evolution driving epidemics
 - variant Rt model
 - overall incidence from UK Infection Survey
 - describe seasonality-gating vs immuninity-gating
 - potential for seasonality driven epidemics

6. Forecasting
 - MLR models generate accurate short-term forecasts
 - but new variants are appearing too quickly and so prediction threshold is poor
 - analogy to weather fronts
 - DMS escape prior and improved forecasting horizon

7. Big picture of continued evolution
 - potential for another Omicron-like event
   - based on simple statistical model
   - evidence from persistent infections and cryptic lineages
 - should we expect evolutionary rate to slow as immunity broadens?
 - expectations for continued incidence and burden of disease

8. Research priorities going forward
 - continued genomic surveillance and modeling
 - development of new antivirals
 - vaccination strategies to combat antigenic evolution and OAS
	 - universal vaccines?
   - cocktail vaccines?
	 - reducing imprinted response?

-->


<!-- Color ramp: [#5097BA", "#60AA9E", "#75B681", "#8EBC66", "#AABD52", "#C4B945", "#D9AD3D", "#E59637", "#E67030", "#DF4327"] -->

<section data-transition="fade" data-background="#000">
	<h2 class="title">{{ page.title }}</h2>
	<br>&nbsp;<br>
	<p class="title">
	Trevor Bedford (@trvrb)
	<br>
	Fred Hutchinson Cancer Center / Howard Hughes Medical Institute
	<br>
	{{ page.date | date: "%-d %b %Y" }}
	<br>
	{{ page.event }}
	<br>
	{{ page.venue }}
</section>

<!-- Variant viruses introduction -->

<!-- Update with latest data -->
<section>
	<h3>Population immunity has driven a dramatic shift in death toll</h3>
	<img class="stretch" data-src="/images/talks/ncov_deaths_owid_2023_05_15.png">
	<div class="citation">
		<a href="https://ourworldindata.org/covid-deaths">ourworldindata.org</a>
	</div>
</section>

<!-- Update with latest data -->
<section>
	<h3>But this immunity is now driving evolution of the virus</h3>
	<img class="stretch" data-src="/images/talks/ncov_variants_tree_unrooted_2023_05_15.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/gisaid/global/all-time/2023-05-15?l=unrooted">nextstrain.org</a>
	</div>
</section>

<!-- Update with latest data -->
<section>
	<h3>In which new variants emerge that escape from existing population immunity and spread rapidly</h3>
	<img class="stretch" data-src="/images/talks/ncov_frequencies_2023_05_15.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/gisaid/global/all-time/2023-05-15">nextstrain.org</a>
	</div>
</section>

<section class="left-align">
	<h3>1. SARS-CoV-2 genome evolution</h3>
	<h3>2. Variant frequency dynamics</h3>
	<h3>3. Evolution driving epidemics</h3>
	<h3>4. Forecasting</h3>
	<h3>5. Continued evolution</h3>
</section>

<section data-transition="fade" data-background="#5097BA">
	<h1 class="title">SARS-CoV-2 genome evolution</h1>
</section>

<!-- Update with latest data -->
<section>
	<h3>Mutations at spike S1 propel escape from population immunity</h3>
 	<img class="stretch" data-src="/images/talks/ncov_mutation_rate_spike_clock_2023_05_15.png">
	<div class="citation">
		<a href="https://nextstrain.org/ncov/gisaid/global/all-time/2023-05-15?branches=hide&l=scatter&scatterY=S1_mutations">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>These mutations are continuing just as quickly post-Omicron</h3>
 	<img class="stretch" data-src="/images/talks/adaptive_evolution_rates_sars_cov_2.png">
	<div class="citation">
		<a href="https://github.com/blab/adaptive-evolution">Kistler and Bedford. 2023. bioRxiv.</a>
	</div>
</section>

<section>
	<h3>And are accruing much more rapidly than other endemic viruses</h3>
 	<img class="stretch" data-src="/images/talks/adaptive_evolution_rates_comparison.png">
	<div class="citation">
		<a href="https://github.com/blab/adaptive-evolution">Kistler and Bedford. 2023. bioRxiv.</a>
	</div>
</section>

<section>
	<h3>Genome correlation analysis</h3>
</section>

<section>
	<h3>Genome dN/dS analysis</h3>
</section>

<!-- Variant frequency dynamics -->

<section data-transition="fade" data-background="#60AA9E">
	<h1 class="title">Variant frequency dynamics</h1>
</section>

<section>
	<h3>Population genetic expectation of variant frequency under selection</h3>
	<p>$x' = \frac{x \, (1+s)}{x \, (1+s) + (1-x)}$ for frequency $x$ over one generation with selective advantage $s$</p>
	<p>$x(t) = \frac{x_0 \, (1+s)^t}{x_0 \, (1+s)^t + (1-x_0)}$ for initial frequency $x_0$ over $t$ generations</p>
	<p>Trajectories are linear once logit transformed via $\mathrm{log}(\frac{x}{1 - x})$</p>
	<img class="stretch" src="/images/talks/ncov_variants_selection_logit_trajectories.png">
</section>

<section>
	<h3>Variants show consistent frequency dynamics in logit space</h3>
	<img class="stretch" src="/images/talks/ncov_variants_omicron_countries_frequencies_logit_2022_04_08.png">
</section>

<!-- Update with more recent trajectories -->
<section>
	<h3>Variants show consistent frequency dynamics in logit space</h3>
	<img class="stretch" src="/images/talks/ncov_variants_delta_countries_frequencies_logit_2021_09_07.png">
</section>

<!----------------------------------------------------------------------->

<section>
	<h3>Multinomial logistic regression</h3>
	<p>
		Multinomial logistic regression models the probability of a virus sampled at time $t$ belonging to
		variant $i$ as
	</p>
	<p>
		$$\mathrm{Pr}(X = i) = x_i(t) = \frac{p_i \, \mathrm{exp}(f_i \, t)}{\sum_{1 \le j \le n} p_j \, \mathrm{exp}(f_j \, t) }$$
	</p>
	<p>
		where the model has $2n$ parameters consisting of $p_i$ the frequency of variant $i$ at initial timepoint
		and $f_i$ the growth rate or fitness of variant $i$ for $n$ variants.
	</p>
	<p>
		The model is fit to minimize "log loss" of predicted variant vs observed variant across observations in
		dataset.
	</p>
</section>

<section>
	<h3>Multinomial logistic regression fits variant frequencies well</h3>
	<img class="stretch" src="/images/talks/sarscov2_variant_rt_logistic_regression_2021_09_01.png">
</section>

<section>
	<h3>Consistent fitness advantage of BA.5 across countries</h3>
	<img class="stretch" src="/images/talks/ncov_variants_ba5_countries_frequencies_logit_2022_08_01.png">
</section>

<section>
	<h3>Despite similar rates of displacement, BA.5 epidemics vary</h3>
	<img class="stretch" src="/images/talks/ncov_variants_ba5_countries_partitioned_cases_2022_08_01.png">
</section>

<section>
	<h3>Despite similar rates of displacement, BA.5 epidemics vary</h3>
	<img class="stretch" src="/images/talks/ncov_variants_ba5_countries_partitioned_log_cases_2022_08_01.png">
</section>

<section>
	<h3>These differences can be explained by consistent growth advantage of BA.5, but different baseline Rt across countries</h3>
	<img class="stretch" src="/images/talks/ncov_variants_ba5_countries_rt_2022_08_01.png">
	<div class="citation">
		Model from <a href="/papers/figgins-rt-from-frequency-dynamics/">Figgins and Bedford. 2022. medRxiv.</a>
	</div>
</section>

<section>
 <h3>May 17: fitness advantage of BA.4/BA.5 clear even though rare</h3>
 <p>Multinomial logistic regression should work well for SARS-CoV-2 prediction, except emergence of new
	 variants limits prediction horizon</p>
 <img class="stretch" data-src="/images/talks/ncov_variants_rt_us_frequencies_logit_2022_05_17.png">
</section>

<!-- Emerging variants -->

<section data-transition="fade" data-background="#75B681">
	<h1 class="title">Emerging variants</h1>
</section>

<section>
 <h3>Over 350 Pango lineages designated in 2022</h3>
 <p>Emerging sublineages within BA.2.75 focusing on BA.2.75.2 and emerging lineages within BA.5
	 focusing on BA.5.3.1.1.1.1.1 ie BQ.1</p>
 <img class="stretch" data-src="/images/talks/ncov_variants_tree_pango_2022_09_29.png">
 <div class="citation">
	 <a href="https://nextstrain.org/nextclade/sars-cov-2?branchLabel=aa&label=clade:21M%20%28Omicron%29">nextstrain.org</a>
 </div>
</section>

<section>
 <h3>BA.2.75 and sublineage BA.2.75.2 emerging from India</h3>
 <img class="stretch" data-src="/images/talks/ncov_variants_ba275_tree_map.png">
 <div class="citation">
	 <a href="https://nextstrain.org/groups/blab/ncov/ba275-in-india">nextstrain.org</a>
 </div>
</section>

<section>
	<h3>BA.2.75.2 and BQ.1 show selective advantage in UK and US</h3>
	<p>BA.2.75.2 has R346T and F486S on top of BA.2.75 and BQ.1 has K444T, N460K on top of BA.5</p>
	<img class="stretch" src="/images/talks/ncov_variants_ba275_logit_frequencies_2022_09_29.png">
</section>

<section>
	<h3>BQ.1 has Rt in the US of ~1.4, approaching that of BA.5 in May</h3>
	<img class="stretch" src="/images/talks/ncov_variants_ba275_rt_log_cases_2022_09_29.png">
	<div class="citation">
		Model from <a href="/papers/figgins-rt-from-frequency-dynamics/">Figgins and Bedford. 2022. medRxiv.</a>
	</div>
</section>

<section>
	<h3>However, multiple low frequency Pango lineages that may compete with BA.2.75.2 and BQ.1</h3>
	<img class="stretch" src="/images/talks/ncov_variants_emerging_variants_cov-spectrum_2022_09_29.png">
	<div class="citation">
		<a href="https://cov-spectrum.org/collections/24">CoV-Spectrum.org</a>
	</div>
</section>

<!-- Seasonality and near-term circulation -->

<section data-transition="fade" data-background="#8EBC66">
	<h1 class="title">Seasonality and near-term circulation</h1>
</section>

<section>
	<h3>Seasonality clearly evidence in 2020-2021 winter epidemic</h3>
	<p>Rt analysis suggests a ~30% transmission advantage going from Aug 2020 to Nov 2020</p>
	<img class="stretch" src="/images/talks/ncov_rt_across_states_2020_11_13.jpg">
	<div class="citation">
		Data from rt.live
	</div>
</section>

<!-- Update with BQ.1 -->
<section>
	<h3>Seasonality alone unlikely to drive BA.5 epidemic, but seasonality + novel variants will likely drive epidemics</h3>
	<img class="stretch" src="/images/talks/ncov_variants_rt_us_log_cases_2022_09_29.png">
	<div class="citation">
		Model from <a href="/papers/figgins-rt-from-frequency-dynamics/">Figgins and Bedford. 2022. medRxiv.</a>
	</div>
</section>

<section>
	<h3>Generally, we expect faster antigenic drift to smooth summer vs winter circulation</h3>
	<img class="stretch" src="/images/talks/ncov_seasonality_sirs_model_varying_waning.png">
	<div class="citation">
		<a href="https://twitter.com/trvrb/status/1554890573781168128">@trvrb</a>
	</div>
</section>

<section class="left-align">
	<h3>Heading into fall, we very roughly have:</h3>
	<p>
	<ul>
		<li>
			40% of the population with BA.2, BA.4, BA.5 in Mar 1 to Sep 15 (16.3M confirmed cases
			and 8x under-reporting)
		</li>
		<li>
			40% of the population with BA.1 infection in Jan/Feb (24.1M confirmed cases and
			5x under-reporting)
		</li>
		<li>
			20% of the population vaccinated, boosted or with pre-Omicron infection
		</li>
	</ul>
	</p>
</section>

<!-- Continued work on forecasting -->

<section data-transition="fade" data-background="#AABD52">
	<h1 class="title">Continued work on forecasting</h1>
</section>

<section>
	<h3>Could we predict the spread of new mutations using DMS data?</h3>
	<p>Perhaps this worked for 486V in BA.4/BA.5</p>
	<div class="left" style="float:left; width:64%">
		<img data-src="/images/talks/ncov_omicron_dms_sites_bloom_2021_12_20.png">
	</div>
	<div class="right" style="float:right; width:34%">
		<img data-src="/images/talks/ncov_variants_south_africa_ba4_ba5_logit_frequencies_2022_04_19.png">
	</div>
	<div class="citation-left">
		<a href="https://academic.oup.com/ve/article/8/1/veac021/6549895">Greaney et al. 2022. Virus Evol.</a>
	</div>
</section>

<section>
	<h3>Now working from Jesse's calculator using panel of monoclonals known to neutralize BA.2</h3>
	<div class="left" style="float:left; width:60%">
		<img data-src="/images/talks/ncov_escape_calculator_bloom_2022_09_29.png">
	</div>
	<div class="right" style="float:right; width:38%">
		<img data-src="/images/talks/ncov_escape_tree_2022_09_29.png">
	</div>
	<div class="citation-left">
		<a href="https://jbloomlab.github.io/SARS2_RBD_Ab_escape_maps/escape-calc/">Bloom. 2022. GitHub.</a>
	</div>
	<div class="citation">
		<a href="https://nextstrain.org/groups/blab/ncov/escape?branchLabel=emerging_lineage">nextstrain.org</a>
	</div>
</section>

<section>
	<h3>Proof-of-principle that we can use immune escape to predict lineage fitness</h3>
	<img class="stretch" src="/images/talks/ncov_escape_growth_advantage_correlation_2022_09_29.png">
</section>

<section>
	<h3>Acknowledgements</h3>

	<p class="even-smaller">
		<b>SARS-CoV-2 genomic epi</b>: Data producers from all over the world, GISAID and the Nextstrain team
	</p>

	<p class="tiny"><b>Bedford Lab</b>:
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/john-huddleston.jpg"> John Huddleston,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/james-hadfield.jpg"> James Hadfield,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/katie-kistler.jpg"> Katie Kistler,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/thomas-sibley.jpg"> Thomas Sibley,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/jover-lee.jpg"> Jover Lee,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/cassia-wagner.jpg"> Cassia Wagner,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/miguel-paredes.jpg"> Miguel Paredes,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/nicola-mueller.jpg"> Nicola Müller,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/marlin-figgins.jpg"> Marlin Figgins,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/victor-lin.jpg"> Victor Lin,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/jennifer-chang.jpg"> Jennifer Chang,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/allison-li.jpg"> Allison Li,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/eslam-abousamra.jpg"> Eslam Abousamra,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/donna-modrell.jpg"> Donna Modrell,</span> &hairsp;
		<span class="nobreak"><img width=35 class="img-avatar" src="/images/team/cecile-tran-kiem.jpg"> Cécile Tran Kiem</span>
	</p>

	<div class="pull-right" style="vertical-align: bottom; display: table-cell;">
		<img width="11%" data-src="/images/talks/logo_fred_hutch_vertical.png">
		&nbsp; &nbsp;
		<img width="8%" data-src="/images/talks/logo_pew.png">
		&nbsp; &nbsp;
		<img width="14%" data-src="/images/talks/logo_bmgf.png">
		&nbsp; &nbsp;
		<img width="12%" data-src="/images/talks/logo_gates_ventures.png">
		&nbsp; &nbsp;
		<img width="11%" data-src="/images/talks/logo_wellcome_trust.jpg">
		&nbsp; &nbsp;
		<img width="7%" data-src="/images/talks/logo_nih.jpg">
		&nbsp; &nbsp;
		<img width="8%" data-src="/images/talks/logo_hhmi.jpg">
	</div>
</section>
